0001140361-15-021768.txt : 20150526 0001140361-15-021768.hdr.sgml : 20150525 20150526195224 ACCESSION NUMBER: 0001140361-15-021768 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150526 FILED AS OF DATE: 20150526 DATE AS OF CHANGE: 20150526 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ajer Jeffrey Robert CENTRAL INDEX KEY: 0001557533 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 15890724 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0306 4 2015-05-26 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001557533 Ajer Jeffrey Robert C/O BIOMARIN PHARMACEUTICAL INC., 770 LINDARO ST. SAN RAFAEL CA 94901 0 1 0 0 SVP, Chief Commercial Of Common Stock 2015-05-26 2015-05-26 4 S 0 1625 126.5523 D 39245 D Trade made pursuant to a 10b5-1 plan executed May 11, 2015. The price in column 4 is a weighted average price. The price actually received ranged from $125.64 to $128.47. The reporting person shall provide to the issuer, and security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price. /s/ Laura Randall Woodhead, Attorney-in-Fact 2015-05-26